Anonymous
Guest
Anonymous
Guest
Looks like one of Intuitives biggest markets is getting some competition by a company names Titan Medical. Any feedback on these guys?
Looks like one of Intuitives biggest markets is getting some competition by a company names Titan Medical. Any feedback on these guys?
The previous post states that patent infringement by Titan is no problem due to the ending of many patents of ISRG by 2012.
However, ISRG is known to defend their IP in an agressive manner to knock out competition. I state that they (i.e. ISRG) will be able to maintain a strong IP portfolio by making small technological changes and thereby restore/renew IP rights. In that way they will be able to keep a firm grip on the market and still be able to destroy possible competition, even long after 2012.
So I think Titan must have found another method to circumvent the problem with IP infringement of Intuitive's IP. Does somebody have a clue about the strategy of Titan concerning this matter?
I'm not sure exactly what the claims are in the Intuitive IP, but there are couple other surgical systems in the market (smaller and definitely not as successful....RoboDoc, Acrobot, Cyberknife) that are different but function in a lot of similar ways and they all got around the IP. - which to me suggests that the claims are probably more specific to how the da Vinci does what it does - and not so general - so there are opportunities for finding new engineering solutions to accomplish the same tasks. I think the big difference between the Amadeus and Da Vinci is that the Amadeus is putting more emphasis on their Haptics capability and the Telesurgical capabilities - I read somewhere that Titan has the current record for longest distance telesurgery...but dont quote me.
Titan stock is up to $2.30 per share from .30 cents a share a few months ago, only about 800 percent.
THat performance is impressive.
How is Intuitive's stock doing??
What a great investment!!!! and they haven't even set a launch date for their system!!! sky's the limit for those of us that invested in Titan early...... the only question now is do you invest more when it is already at $2.30????
I'm not sure exactly what the claims are in the Intuitive IP, but there are couple other surgical systems in the market (smaller and definitely not as successful....RoboDoc, Acrobot, Cyberknife) that are different but function in a lot of similar ways and they all got around the IP. - which to me suggests that the claims are probably more specific to how the da Vinci does what it does - and not so general - so there are opportunities for finding new engineering solutions to accomplish the same tasks. I think the big difference between the Amadeus and Da Vinci is that the Amadeus is putting more emphasis on their Haptics capability and the Telesurgical capabilities - I read somewhere that Titan has the current record for longest distance telesurgery...but dont quote me.
Cyberknife is radiation, not actual surgery like the dV.
Titan, imho, is taking notes from ISI and their customers and will plan to do exactly the opposite. Titan will probably target small hospitals or hospitals that haven't pulled the trigger on a system yet (Consider there are over 6000 hospitals in the US, and 1200 or so dV's have been sold. Many hospitals have more than one.) and offer a robot at $500K or so.
ISI is preparing for this by taking back all the old 1st gen robots. They'll refurbish them and sell them around the same price....or try to enter 3rd world countries with them. Hospitals have been abused by ISI and they will make it known. Only problem is, everyone at ISI has made the money they wanted so they won't learn a lesson. These people don't care about karma and will just move on to something else. In the end, ISI will make a ton of cash by using unethical practices (both w/ employees and with customers) and ultimately win. Unless they get taken down from, just guessing here, cooking the books by claiming more surgeries than actually have taken place. But who knows? Just a shot in the dark.